Literature DB >> 26885093

Consistency analysis of contrast-enhanced ultrasound and contrast-enhanced CT in diagnosis of small hepatocellular carcinoma.

Jun-Jie Liu1, Hong-Xue Li1, Zhao-Bei Chen1, Wei-Ping Yang1, Sheng-Fa Zhao1, Jie Chen2, Tao Bai2, Hang Li1, Le-Qun Li2.   

Abstract

UNLABELLED: To compare the consistency of contrast-enhanced ultrasound (CEUS) and contrast-enhance CT (CECT) in diagnosis of 1~2 cm and 2.1~3 cm small hepatocellular carcinoma (HCC) and evaluate the value of CEUS in diagnosis of HCC.
METHODS: A total of 74 patients (89 lesions) with small HCC and cirrhosis background were retrospectively analyzed. All of the eighty-nine lesions were confirmed by histopathological examination of surgical samples or needle biopsy. All the cases were divided into 1~2 cm group and 2.1~3 cm group. The CEUS and CECT enhanced pattern and diagnosis results of the two groups were compared and the consistency between the two imaging methods were statistically analyzed.
RESULTS: In the diagnosis of 1.0-2.0 cm HCC, CEUS and CECT had a moderate consistency in arterial phase, CEUS showed a tolerable consistency with CECT in portal venous and delayphase. The two imaging methods have a better consistency for the diagnosis in 2.1-3.0 cm HCC.
CONCLUSION: CEUS can be used as a supplement to provide important diagnostic information in clinical practice when positive results or definite diagnoses cannot obtain.

Entities:  

Keywords:  Contrast-enhanced ultrasound; enhanced CT; small hepatocellular carcinoma

Year:  2015        PMID: 26885093      PMCID: PMC4723938     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  7 in total

Review 1.  Update on precursor and early lesions of hepatocellular carcinomas.

Authors:  Young Nyun Park
Journal:  Arch Pathol Lab Med       Date:  2011-06       Impact factor: 5.534

2.  Optimization of imaging diagnosis of 1-2 cm hepatocellular carcinoma: an analysis of diagnostic performance and resource utilization.

Authors:  Korosh Khalili; Tae Kyoung Kim; Hyun-Jung Jang; Masoom A Haider; Luluel Khan; Maha Guindi; Morris Sherman
Journal:  J Hepatol       Date:  2010-09-22       Impact factor: 25.083

3.  Contrast-enhanced ultrasound for characterisation of hepatic lesions appearing non-hypervascular on CT in chronic liver diseases.

Authors:  H Maruyama; M Takahashi; H Ishibashi; M Yoshikawa; O Yokosuka
Journal:  Br J Radiol       Date:  2011-01-11       Impact factor: 3.039

4.  Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver--update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS.

Authors:  M Claudon; C F Dietrich; B I Choi; D O Cosgrove; M Kudo; C P Nolsøe; F Piscaglia; S R Wilson; R G Barr; M C Chammas; N G Chaubal; M-H Chen; D A Clevert; J M Correas; H Ding; F Forsberg; J B Fowlkes; R N Gibson; B B Goldberg; N Lassau; E L S Leen; R F Mattrey; F Moriyasu; L Solbiati; H-P Weskott; H-X Xu
Journal:  Ultraschall Med       Date:  2012-11-05       Impact factor: 6.548

5.  Correlation between enhancement pattern of hepatocellular carcinoma on real-time contrast-enhanced ultrasound and tumour cellular differentiation on histopathology.

Authors:  G-J Liu; H-X Xu; M-D Lu; X-Y Xie; Z-F Xu; Y-L Zheng; J-Y Liang
Journal:  Br J Radiol       Date:  2006-09-27       Impact factor: 3.039

Review 6.  Management of hepatocellular carcinoma: The role of contrast-enhanced ultrasound.

Authors:  Shu-Guang Zheng; Hui-Xiong Xu; Lin-Na Liu
Journal:  World J Radiol       Date:  2014-01-28

7.  Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.

Authors:  C Egger; R S Goertz; D Strobel; M Lell; M F Neurath; F Knieling; M Scharf
Journal:  Ultraschall Med       Date:  2012-11-15       Impact factor: 6.548

  7 in total
  6 in total

1.  Clinical value of combining transvaginal contrast-enhanced ultrasonography with serum human epididymisprotein-4 and the resistance index for early-stage epithelial ovarian cancer.

Authors:  Wu Meng; Wang Ying; Zheng Qichao; Li Ping; Tang Jie
Journal:  Saudi Med J       Date:  2017-06       Impact factor: 1.484

2.  Study on the diagnosis of small hepatocellular carcinoma caused by hepatitis B cirrhosis via multi-slice spiral CT and MRI.

Authors:  Mei Wang; Congxin Wei; Zhaojuan Shi; Jianzhong Zhu
Journal:  Oncol Lett       Date:  2017-10-31       Impact factor: 2.967

3.  Dysregulation of miR-3607 predicts prognosis of hepatocellular carcinoma and regulates tumor cell proliferation, migration and invasion.

Authors:  Wenwen Dou; Min Yang; Yan Su; Ruizhu Xie
Journal:  Diagn Pathol       Date:  2020-05-13       Impact factor: 2.644

4.  Combination of acoustic radiation force impulse imaging, serological indexes and contrast-enhanced ultrasound for diagnosis of liver lesions.

Authors:  Xiao-Lan Sun; Hui Yao; Qiong Men; Ke-Zhu Hou; Zhen Chen; Chang-Qing Xu; Li-Wei Liang
Journal:  World J Gastroenterol       Date:  2017-08-14       Impact factor: 5.742

5.  Application of contrast-enhanced ultrasound and enhanced CT in diagnosis of liver cancer and evaluation of radiofrequency ablation.

Authors:  Shuhong Kong; Xuewang Yue; Sheng Kong; Yujie Ren
Journal:  Oncol Lett       Date:  2018-06-05       Impact factor: 2.967

Review 6.  Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review.

Authors:  Aakash Desai; Sonia Sandhu; Jin-Ping Lai; Dalbir Singh Sandhu
Journal:  World J Hepatol       Date:  2019-01-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.